# An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis

> **NCT04946669** · EARLY_PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Dermatomyositis
- Abatacept

## Interventions

- **DRUG:** Abatacept

## Key facts

- **NCT ID:** NCT04946669
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-07-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04946669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04946669, "An Exploratory Study on the Efficacy and Safety of Abatacept in the Treatment of Refractory Dermatomyositis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT04946669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*